# OnCo record auger-electron-therapy (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/auger-electron-therapy/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "auger-electron-therapy" ;
  schema:name "Auger-electron therapy"@en ;
  schema:description "Auger-electron therapy uses radioactive atoms such as iodine-125 or terbium-161 that release cascades of low-energy electrons travelling only nanometres to micrometres, so they kill a cell only if the atom sits on or inside its DNA and spare the neighbours. Terbium-161 can replace lutetium-177 in existing PSMA ligands; true nuclear delivery remains preclinical."@en ;
  schema:url <https://onco.cc/technologies/auger-electron-therapy/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?term=terbium-161> ;
  onco:status "preclinical" ;
  onco:tag "frontier", "radical" ;
  onco:sections <https://onco.cc/fronts/radiopharma/> ;
  onco:technologies <https://onco.cc/technologies/radioligand-therapy/>, <https://onco.cc/technologies/targeted-alpha-therapy/>, <https://onco.cc/technologies/radioimmunotherapy/> ;
  onco:targets <https://onco.cc/targets/psma/>, <https://onco.cc/targets/sstr2/> ;
  onco:terms <https://onco.cc/terms/alpha-vs-beta/>, <https://onco.cc/terms/dosimetry/> .